Form 8-K - Current report:
SEC Accession No. 0001193125-21-190656
Filing Date
2021-06-15
Accepted
2021-06-15 08:40:30
Documents
12
Period of Report
2021-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d175631d8k.htm   iXBRL 8-K 37837
  Complete submission text file 0001193125-21-190656.txt   165681

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrn-20210614.xsd EX-101.SCH 3075
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20210614_lab.xml EX-101.LAB 18839
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20210614_pre.xml EX-101.PRE 11842
5 EXTRACTED XBRL INSTANCE DOCUMENT d175631d8k_htm.xml XML 3885
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 211016987
SIC: 2834 Pharmaceutical Preparations